The decision expands patient access beyond the United States and sets reimbursement negotiations across France, Germany, and the UK.

Astronomers identified atmospheric signatures on a rocky exoplanet 40 light-years away — the strongest biosignature candidate to date.

The facility can inject up to five million tonnes of CO₂ annually, backed by Maersk, Ørsted, and EU Innovation Fund financing.

A materials simulation run completed faster on IBM's utility-scale quantum processor than on the largest classical approximation — a narrow but symbolic win.

The France-based megaproject sustained a burning plasma configuration for longer than any prior test, reviving investor interest in grid-scale fusion timelines.

DeepMind's latest structural biology tools are shortening preclinical timelines for Roche, AstraZeneca, and a wave of biotech startups.